Download - Daravita ANDA Form Case 114-Cv-01118-UNA

Transcript
  • IN THE UNITED STATES DISTRICT COURT

    FOR THE DISTRICT OF DELAWARE

    DARAVITA LIMITED,

    Plaintiff,

    v.

    ACTAVIS LABORATORIES FL, INC.,

    ANDRX CORPORATION, ACTAVIS

    PHARMA, INC., and ACTAVIS, INC.,

    Defendants.

    )

    )

    )

    )

    )

    )

    )

    )

    )

    )

    )

    C.A. No. ______________

    SUPPLEMENTAL INFORMATION FOR PATENT CASES

    INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA)

    Plaintiff hereby provides the information below with respect to the deadlines set forth in

    21 U.S.C. 355(j):

    Date Patentee(s) Received Notice: August 12, 2014

    Date of Expiration of Patent: U.S. Patent No. 6,228,398: Nov. 1, 2019

    U.S. Patent No. 6,902,742: Nov. 1, 2019

    Thirty-Month Stay Deadline: February 12, 2017

    September 3, 2014

    MORRIS, NICHOLS, ARSHT & TUNNELL LLP

    /s/ Maryellen Noreika Jack B. Blumenfeld (#1014)

    Maryellen Noreika (#3208)

    Jeremy A. Tigan (#5239)

    1201 N. Market Street

    P.O. Box 1347

    Wilmington, DE 19899-1347

    (302) 658-9200

    [email protected]

    [email protected]

    [email protected]

    Attorneys for Daravita Limited

    8498534

    Case 1:14-cv-01118-UNA Document 3 Filed 09/03/14 Page 1 of 1 PageID #: 45